LCM Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $367K | Sell |
15,139
-3,849
| -20% | -$93.3K | 0.19% | 68 |
|
|
2025
Q1 | $481K | Sell |
18,988
-336
| -2% | -$8.51K | 0.28% | 51 |
|
|
2024
Q4 | $513K | Sell |
19,324
-166
| -0.9% | -$4.4K | 0.29% | 50 |
|
|
2024
Q3 | $564K | Buy |
19,490
+31
| +0.2% | +$897 | 0.32% | 45 |
|
|
2024
Q2 | $544K | Sell |
19,459
-29
| -0.1% | -$811 | 0.34% | 45 |
|
|
2024
Q1 | $541K | Sell |
19,488
-144
| -0.7% | -$4K | 0.35% | 44 |
|
|
2023
Q4 | $565K | Sell |
19,632
-187
| -0.9% | -$5.38K | 0.41% | 42 |
|
|
2023
Q3 | $657K | Buy |
19,819
+123
| +0.6% | +$4.08K | 0.54% | 35 |
|
|
2023
Q2 | $722K | Buy |
19,696
+301
| +2% | +$11K | 0.59% | 34 |
|
|
2023
Q1 | $791K | Buy |
19,395
+621
| +3% | +$25.3K | 0.69% | 26 |
|
|
2022
Q4 | $962K | Buy |
18,774
+9
| +0% | +$461 | 0.94% | 19 |
|
|
2022
Q3 | $821K | Sell |
18,765
-52
| -0.3% | -$2.28K | 0.87% | 18 |
|
|
2022
Q2 | $987K | Sell |
18,817
-86
| -0.5% | -$4.51K | 0.97% | 17 |
|
|
2022
Q1 | $979K | Buy |
18,903
+131
| +0.7% | +$6.79K | 0.79% | 21 |
|
|
2021
Q4 | $1.11M | Buy |
18,772
+510
| +3% | +$30.1K | 0.86% | 20 |
|
|
2021
Q3 | $785K | Sell |
18,262
-256
| -1% | -$11K | 0.66% | 26 |
|
|
2021
Q2 | $725K | Buy |
18,518
+3,742
| +25% | +$147K | 0.6% | 32 |
|
|
2021
Q1 | $535K | Sell |
14,776
-427
| -3% | -$15.5K | 0.48% | 41 |
|
|
2020
Q4 | $559K | Buy |
+15,203
| New | +$559K | 0.53% | 36 |
|